Close X
Attorney Spotlight

What emerging trend in shareholder litigation does Britt Latham find most interesting in his practice today?    Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more


Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

DOJ's New FCPA Guidance: Meeting the Requirements, Leveraging Self-Reporting, Navigating its Interplay with the Yates Memo

Events

June 9, 2016

Bass, Berry & Sims attorneys Thad McBride and Cheryl Palmeri will serve as panelists on a webinar titled, "DOJ's New FCPA Guidance: Meeting the Requirements, Leveraging Self-Reporting, Navigating its Interplay with the Yates Memo" hosted by Strafford. This webinar will provide participants a valuable overview of the implications of the FCPA Guidance and best practices in navigating a changing enforcement environment.

Topics will include: 
  • What light does the new guidance shed on the reporting process?
  • What changes are anticipated and how does meeting the requirements impact the ultimate resolution of the matter?
  • What is the interplay between the new FCPA guidance and the 2015 Yates memo?
  • How does the FCPA guidance change the landscape for self-reporting?

The webinar will be held on June 9 from 1:00 – 2:30 p.m. EDT. For more information and registration, visit the Strafford website.


Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.